|
Name |
(1R,2R,3S,7R,9R,10S,11R,12S,14S,15R,16S)-16-benzyl-2,9,12-trihydroxy-5,7,14-trimethyl-13-methylidene-17-azatetracyclo[9.7.0.01,15.03,10]octadec-4-en-18-one
|
Molecular Formula | C28H37NO4 | |
IUPAC Name* |
(1R,2R,3S,7R,9R,10S,11R,12S,14S,15R,16S)-16-benzyl-2,9,12-trihydroxy-5,7,14-trimethyl-13-methylidene-17-azatetracyclo[9.7.0.01,15.03,10]octadec-4-en-18-one
|
|
SMILES |
C[C@H]1C[C@H]([C@H]2[C@H](C=C(C1)C)[C@H]([C@]34[C@@H]2[C@@H](C(=C)[C@H]([C@H]3[C@@H](NC4=O)CC5=CC=CC=C5)C)O)O)O
|
|
InChI |
InChI=1S/C28H37NO4/c1-14-10-15(2)12-21(30)22-19(11-14)26(32)28-23(16(3)17(4)25(31)24(22)28)20(29-27(28)33)13-18-8-6-5-7-9-18/h5-9,11,15-16,19-26,30-32H,4,10,12-13H2,1-3H3,(H,29,33)/t15-,16-,19+,20+,21-,22-,23+,24+,25-,26-,28-/m1/s1
|
|
InChIKey |
JVLHNUNFFFDFDT-XIHPKKOBSA-N
|
|
Synonyms |
Phomopchalasin A
|
|
CAS | NA | |
PubChem CID | 139591044 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 451.6 | ALogp: | 2.4 |
HBD: | 4 | HBA: | 4 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 89.8 | Aromatic Rings: | 5 |
Heavy Atoms: | 33 | QED Weighted: | 0.517 |
Caco-2 Permeability: | -5.335 | MDCK Permeability: | 0.00001050 |
Pgp-inhibitor: | 0.026 | Pgp-substrate: | 0.997 |
Human Intestinal Absorption (HIA): | 0.019 | 20% Bioavailability (F20%): | 0.012 |
30% Bioavailability (F30%): | 0.015 |
Blood-Brain-Barrier Penetration (BBB): | 0.22 | Plasma Protein Binding (PPB): | 79.04% |
Volume Distribution (VD): | 1.489 | Fu: | 14.57% |
CYP1A2-inhibitor: | 0.086 | CYP1A2-substrate: | 0.096 |
CYP2C19-inhibitor: | 0.119 | CYP2C19-substrate: | 0.518 |
CYP2C9-inhibitor: | 0.526 | CYP2C9-substrate: | 0.188 |
CYP2D6-inhibitor: | 0.014 | CYP2D6-substrate: | 0.118 |
CYP3A4-inhibitor: | 0.635 | CYP3A4-substrate: | 0.219 |
Clearance (CL): | 9.452 | Half-life (T1/2): | 0.352 |
hERG Blockers: | 0.221 | Human Hepatotoxicity (H-HT): | 0.75 |
Drug-inuced Liver Injury (DILI): | 0.772 | AMES Toxicity: | 0.023 |
Rat Oral Acute Toxicity: | 0.771 | Maximum Recommended Daily Dose: | 0.952 |
Skin Sensitization: | 0.11 | Carcinogencity: | 0.099 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.009 |
Respiratory Toxicity: | 0.971 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005759 | 0.810 | D0SP3D | 0.231 | ||||
ENC005760 | 0.667 | D09NNH | 0.230 | ||||
ENC003936 | 0.619 | D0V3ZA | 0.230 | ||||
ENC003956 | 0.588 | D0IN7I | 0.228 | ||||
ENC006133 | 0.565 | D0C6NM | 0.228 | ||||
ENC005758 | 0.564 | D05VQI | 0.227 | ||||
ENC004369 | 0.556 | D06CWH | 0.226 | ||||
ENC003955 | 0.552 | D0Z9NZ | 0.225 | ||||
ENC004243 | 0.542 | D06VFO | 0.224 | ||||
ENC004540 | 0.538 | D01TSI | 0.223 |